SCG Chemicals Co. Ltd. engages in the manufacture and distribution of chemical products. It offers polyethylene, polypropylene, and polyvinyl chloride products. Its services include design solutions and financial services. Its products are used in additives and lubricant, agriculture, automotive, building and infrastructure, packaging, medical and healthcare products. The company was founded in April 1995 and is headquartered in Bangkok, Thailand.

Persedo offers neutral grain spirits like whisky, gin, bourbon, and vodka. They offer bulk spirits, spirit enhancements, bulk loading, bulk production, and equipment leasing services.

BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.

CMC Materials, Inc. engages in the development, manufacture, and sale of chemical mechanical planarization consumables products. It operates through the following segments: Electronic Materials and Performance Material. The Electronic Materials segment consists of CMP slurries and polishing pads businesses and KMG electronic chemicals business. The Performance Materials segment includes KMG's heritage pipeline performance and wood treatment businesses and QED business. The firm offers chemical mechanical planarization slurries for polishing many of the conducting, insulating and isolating materials used in integrated circuit devices, and for polishing the disk substrates and magnetic heads used in hard disk drives. It also develops, manufactures and sells chemical mechanical planarization polishing pads, which are used in conjunction with slurries in the chemical mechanical planarization process. The company was founded by William P. Noglows in October 1999 and is headquartered in Aurora, IL.

MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA.

Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. The company’s lead product candidate, APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) for patients undergoing both moderately and highly emetogenic chemotherapy and for the prevention of delayed CINV for patients undergoing moderately emetogenic chemotherapy. APF530 contains the 5-HT3 antagonist granisetron formulated in the Company’s Biochronomer drug delivery system, which allows therapeutic drug levels to be maintained for five days with a single subcutaneous injection.

SDS Biotech manufactures, imports, and sells agrochemicals, functional feeds, industrial antifungal agents, epidemic prevention agents, and specialty chemicals. They continue to support domestic and overseas agriculture as an integrated company. They conducts research and development, manufacturing and sales of active ingredients as an active ingredient manufacturer.

Tulane Educational Fund is a private company headquartered in the United States specializing in radio broadcasting stations.

GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan.

Tomoegawa manufactures paper, electronic device parts, non-woven fabrics, pulp, and composite materials. Their products include industrial paper, electrical insulating paper, light cleaner optres, thermal adhesive film, polishing tape, and fluorine fiber sheets. They also offer import, export, and sales services.

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.

Shanghai Sankeshu Waterproof Technology Co., Ltd., established on 2018-12-14, Business scope includes licensed projects:Various construction activities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in waterproof technology,construction technology,Technology development in the field of new material technology,technology transfer,technical consulting,Technical Services,Import and export,Technology Import and Export,building materials,Instrumentation,Sales of mechanical equipment and spare parts,The following limited branch operations:Manufacture of waterproof building materials.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Guotai Super Power New Materials Co. Ltd. is a private company headquartered in China that manufactures electronic chemical materials.

Dalian Kerong Biotechnology Co., Ltd., established on 2011-12-05, The scope of business includes the development of biotechnology,technical consulting,technology transfer;Domestic general trade,goods,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations can only be operated after obtaining industry permits).****(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Fujian Youda Environmental Protection Material Co., Ltd., established on 2017-05-24, Business scope includes sales and research and development of environmental protection materials,Photoelectric microelectronics and semiconductor high-tech materials(Wet Electronic Chemicals)(according to<safety production license>Listed scope and project scope approved by environmental protection department,Free of Hazardous Chemicals)research and development,Production,Sales;Research and development of chemical engineering technology;Chemical recycling(Free of Hazardous Chemicals);Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Production,Sales:medical instruments,Cosmetics and hygiene products,Non-medical daily protective mask.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Operates as a holding company

Foamix has a strong in-house pipeline of drugs for dermatologic, ophthalmologic and gynecologic indications. The Company’s lead product under development is the first-in-class Topical Minocycline Foam addressing large markets in dermatology and ophthalmology. Minocycline foam demonstrated high efficacy and favorable safety in two phase II clinical studies in Acne and Impetigo patients. Foamix Ltd. is a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foams and OilGel™ products for dermatology, gynecology, wounds and burns as well as ophthalmic disorders.